VE-cadherin-2 inhibitors are a class of chemical compounds designed to target and inhibit VE-cadherin-2, also known as vascular endothelial cadherin-2, a key protein involved in the regulation of cell-cell adhesion within vascular endothelial cells. VE-cadherin-2 is part of the cadherin family of transmembrane proteins, which mediate calcium-dependent adhesion by forming homophilic interactions between adjacent cells. This protein plays a critical role in maintaining the integrity of endothelial junctions, which are essential for the formation and maintenance of blood vessels, as well as for controlling permeability and barrier function. Inhibitors of VE-cadherin-2 are designed to interfere with its adhesive functions, either by blocking its extracellular domains responsible for cell-cell adhesion or by disrupting the intracellular signaling pathways it regulates.
Chemically, VE-cadherin-2 inhibitors can be small molecules, peptides, or antibodies that specifically target the adhesion domains of the protein. These inhibitors may work by binding to the extracellular cadherin repeats, preventing the protein from forming stable homophilic interactions between endothelial cells. Alternatively, some inhibitors may act by interfering with the intracellular interactions between VE-cadherin-2 and cytoskeletal or signaling molecules, thus affecting the stability of endothelial junctions. By inhibiting VE-cadherin-2, researchers can study the role of this protein in vascular biology, particularly in the regulation of endothelial barrier functions and how cellular adhesion impacts vascular integrity. These inhibitors provide important tools for investigating the mechanisms that control endothelial cell junctions, vascular permeability, and the organization of blood vessel networks.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
May induce hypomethylation globally, but could specifically decrease the methylation status of the PCDH12 promoter, leading to a reduction in its expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
By inhibiting histone deacetylase activity, this compound could cause hyperacetylation of histones near the PCDH12 gene, potentially resulting in transcriptional repression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Targets mTOR complex 1, which might downregulate protein synthesis machinery, indirectly leading to a decrease in VE-cadherin-2 synthesis. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, potentially disrupting AKT signaling and subsequent transcription factor activity, resulting in decreased PCDH12 transcription. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Blocks MEK activity, potentially leading to lowered ERK phosphorylation and downstream transcriptional activity, thus reducing PCDH12 expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
By targeting p38 MAPK, this inhibitor can prevent the activation of transcription factors that normally stimulate PCDH12 expression, leading to reduced mRNA levels. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibition by SP600125 could lead to diminished transcription factor activation and therefore lower the transcription rates of genes like PCDH12. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
Specifically inhibits G9a histone methyltransferase, potentially leading to decreased di-methylation of H3K9 near the PCDH12 locus and subsequent transcriptional downregulation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
As a ROCK inhibitor, it may disrupt cytoskeletal dynamics, potentially leading to downregulation of mechanotransduction signals that elevate PCDH12 expression. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Disrupts MDM2 binding, leading to the stabilization of p53, which can have a downstream effect of reducing PCDH12 transcription if p53 acts as a suppressor for this gene. | ||||||